Literature DB >> 17365511

G protein-coupled receptor-mediated ERK1/2 phosphorylation: towards a generic sensor of GPCR activation.

Didier Leroy1, Marc Missotten, Caroline Waltzinger, Thierry Martin, Alexander Scheer.   

Abstract

The development of new analytical methods, aimed at profiling G protein-coupled receptor (GPCR) ligands, regardless of the G protein-coupling pattern of their respective receptor, remains a key goal in drug discovery. Considerable evidence has recently revived the central role that could be played by extracellular-signal-regulated kinase (ERK), the cornerstone protein kinase of the first tyrosine kinase receptor-mediated pathway identified, in response to the activation of various types of GPCRs. Here we reveal a conceptual study in which the potential of ERK phosphorylation is evaluated as a generic readout in response to three different receptors activating three main classes of G proteins: Galphas, Galphai and Galphaq. GPCR-mediated ERK phosphorylation was compared with different readouts such as GTPgammaS, CAMP, or Ca2 +. We propose the measurement of GPCR-activated ERK phosphorylation as an alternative assay to better understand the molecular pharmacology of ligands of promiscuous GPCRs.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17365511     DOI: 10.1080/10799890601112244

Source DB:  PubMed          Journal:  J Recept Signal Transduct Res        ISSN: 1079-9893            Impact factor:   2.092


  7 in total

1.  Activation of G proteins and extracellular signal-regulated kinase 1/2 phosphorylation via human dopamine D4.4 receptors: differential pathway-dependent potencies of receptor agonists.

Authors:  Peter Heusler; Liesbeth Bruins Slot; Isabelle Rauly-Lestienne; Christiane Palmier; Stéphanie Tardif; Amélie Tourette; Marie-Christine Ailhaud; Didier Cussac
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2008-08-06       Impact factor: 3.000

2.  Ligand-induced activation of ERK1/2 signaling by constitutively active Gs-coupled 5-HT receptors.

Authors:  Ping Liu; Yu-Ling Yin; Ting Wang; Li Hou; Xiao-Xi Wang; Man Wang; Guan-Guan Zhao; Yi Shi; H Eric Xu; Yi Jiang
Journal:  Acta Pharmacol Sin       Date:  2019-03-04       Impact factor: 6.150

3.  In vivo and in vitro characterization of a first-in-class novel azole analog that targets pregnane X receptor activation.

Authors:  Madhukumar Venkatesh; Hongwei Wang; Julie Cayer; Melissa Leroux; Dany Salvail; Bhaskar Das; Jay E Wrobel; Sridhar Mani
Journal:  Mol Pharmacol       Date:  2011-04-04       Impact factor: 4.436

4.  Minireview: Targeting GPCR Activated ERK Pathways for Drug Discovery.

Authors:  Haifeng Eishingdrelo; Sathapana Kongsamut
Journal:  Curr Chem Genom Transl Med       Date:  2013-07-26

5.  Vascular wall regulator of G-protein signalling-1 (RGS-1) is required for angiotensin II-mediated blood pressure control.

Authors:  Jyoti Patel; Surawee Chuaiphichai; Gillian Douglas; Caroline M Gorvin; Keith M Channon
Journal:  Vascul Pharmacol       Date:  2018-04-11       Impact factor: 5.773

6.  Orphan GPR26 Counteracts Early Phases of Hyperglycemia-Mediated Monocyte Activation and Is Suppressed in Diabetic Patients.

Authors:  Zahra Abedi Kichi; Lucia Natarelli; Saeed Sadeghian; Mohammad Ali Boroumand; Mehrdad Behmanesh; Christian Weber
Journal:  Biomedicines       Date:  2022-07-19

7.  Development of a novel cell-based, In-Cell Western/ERK assay system for the high-throughput screening of agonists acting on the delta-opioid receptor.

Authors:  Junaid Asghar; Liaque Latif; Stephen P H Alexander; David A Kendall
Journal:  Front Pharmacol       Date:  2022-09-26       Impact factor: 5.988

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.